Pyrazinamide-d3
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Pyrazinamide-d3
Description :
Pyrazinamide-d3 is deuterium labeled Pyrazinamide. Pyrazinamide (Pyrazinecarboxamide; Pyrazinoic acid amide) is a potent and orally active antitubercular antibiotic. Pyrazinamide is a proagent that is converted to the active form pyrazinoic acid (POA) by PZase/nicotinamidase encoded by the pncA gene in M. tuberculosis[1][2].Product Name Alternative :
Pyrazinecarboxamide-d3; Pyrazinoic acid amide-d3UNSPSC :
12352005Hazard Statement :
H302-H315-H319-H335Target :
Antibiotic; Autophagy; Bacterial; Isotope-Labeled CompoundsType :
Isotope-Labeled CompoundsRelated Pathways :
Anti-infection; Autophagy; OthersApplications :
COVID-19-immunoregulationField of Research :
InfectionPurity :
99.84Solubility :
10 mM in DMSOSmiles :
NC(C1=NC([2H])=C([2H])N=C1[2H])=OMolecular Formula :
C5H2D3N3OMolecular Weight :
126.13Precautions :
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501References & Citations :
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Y Zhang, et al. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide. J Bacteriol. 1999 Apr;181 (7) :2044-9.|[3]Ying Zhang, et al. Mechanisms of Pyrazinamide Action and Resistance. Microbiol Spectr. 2014 Aug;2 (4) :MGM2-0023-2013.Shipping Conditions :
Blue IceStorage Conditions :
-20°C, 3 years (Powder)Scientific Category :
Isotope-Labeled CompoundsClinical Information :
No Development ReportedCAS Number :
[1432059-16-9]

